Impaired lysogenisation of the Escherichia coli rpoA341 mutant by bacteriophage lambda is due to the inability of CII to act as a transcriptional activator. 1997

M Obuchowski, and H Giladi, and S Koby, and A Szalewska-Pałasz, and A Wegrzyn, and A B Oppenheim, and M S Thomas, and G Wegrzyn
Department of Molecular Biology, University of Gdansk, Poland.

The C-terminus of the alpha subunit of Escherichia coli RNA polymerase is known to function in transcriptional activation at certain promoters. This region was previously shown to be necessary for full activation of the pE promoter by the phage lambda CII protein in vitro. In this work we investigated the inability of phage lambda to follow the lysogenic pathway in cells carrying the point mutation rpoA341 (a change of lysine 271 to glutamic acid). We found that neither overexpression of the cII gene nor stabilisation of the CII protein by the can1 mutation or by cIII gene overexpression was able to suppress the block in lysogenisation. In contrast, the lambda cin1 phage, which carries a CII-independent promoter for the expression of the cI gene, was able to efficiently lysogenise the rpoA341 mutant strain. Furthermore, the rpoA341 mutation prevented the activation of pE-lacZ and pI-lacZ transcriptional fusions by CII. Therefore we conclude that transcriptional activation by the cII gene product is abolished by the rpoA341 mutation, most probably due to impaired interaction between the CII activator and mutant RNA polymerase. The inability of RNA polymerase to respond to CII results in the impairment of lysogenisation of the rpoA341 mutant by phage lambda.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010582 Bacteriophage lambda A temperate inducible phage and type species of the genus lambda-like viruses, in the family SIPHOVIRIDAE. Its natural host is E. coli K12. Its VIRION contains linear double-stranded DNA with single-stranded 12-base 5' sticky ends. The DNA circularizes on infection. Coliphage lambda,Enterobacteria phage lambda,Phage lambda,lambda Phage
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription
D014158 Transcription, Genetic The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION. Genetic Transcription
D014764 Viral Proteins Proteins found in any species of virus. Gene Products, Viral,Viral Gene Products,Viral Gene Proteins,Viral Protein,Protein, Viral,Proteins, Viral
D015964 Gene Expression Regulation, Bacterial Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in bacteria. Bacterial Gene Expression Regulation,Regulation of Gene Expression, Bacterial,Regulation, Gene Expression, Bacterial

Related Publications

M Obuchowski, and H Giladi, and S Koby, and A Szalewska-Pałasz, and A Wegrzyn, and A B Oppenheim, and M S Thomas, and G Wegrzyn
October 1996, FEMS microbiology letters,
M Obuchowski, and H Giladi, and S Koby, and A Szalewska-Pałasz, and A Wegrzyn, and A B Oppenheim, and M S Thomas, and G Wegrzyn
June 2000, Journal of bacteriology,
M Obuchowski, and H Giladi, and S Koby, and A Szalewska-Pałasz, and A Wegrzyn, and A B Oppenheim, and M S Thomas, and G Wegrzyn
January 1998, Acta biochimica Polonica,
M Obuchowski, and H Giladi, and S Koby, and A Szalewska-Pałasz, and A Wegrzyn, and A B Oppenheim, and M S Thomas, and G Wegrzyn
January 1986, Gene,
M Obuchowski, and H Giladi, and S Koby, and A Szalewska-Pałasz, and A Wegrzyn, and A B Oppenheim, and M S Thomas, and G Wegrzyn
December 1992, Gene,
M Obuchowski, and H Giladi, and S Koby, and A Szalewska-Pałasz, and A Wegrzyn, and A B Oppenheim, and M S Thomas, and G Wegrzyn
November 2014, The Journal of biological chemistry,
M Obuchowski, and H Giladi, and S Koby, and A Szalewska-Pałasz, and A Wegrzyn, and A B Oppenheim, and M S Thomas, and G Wegrzyn
January 1986, Journal of molecular biology,
M Obuchowski, and H Giladi, and S Koby, and A Szalewska-Pałasz, and A Wegrzyn, and A B Oppenheim, and M S Thomas, and G Wegrzyn
August 1982, The Journal of biological chemistry,
M Obuchowski, and H Giladi, and S Koby, and A Szalewska-Pałasz, and A Wegrzyn, and A B Oppenheim, and M S Thomas, and G Wegrzyn
May 1985, Journal of molecular biology,
M Obuchowski, and H Giladi, and S Koby, and A Szalewska-Pałasz, and A Wegrzyn, and A B Oppenheim, and M S Thomas, and G Wegrzyn
December 1973, Journal of molecular biology,
Copied contents to your clipboard!